The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons.
It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.
Clinical Review of the Impacts of Hepatitis C: Short Life Working Group Report for the Scottish Government
Visit https://beta.gov.scot/publications/clinical-review-impacts-hepatitis-c-short-life-working-group-report/
This independent clinical review commissioned by the Scottish Government assesses the impacts of chronic hepatitis C infection on the health and wellbeing of individuals affected by contaminated blood and blood products. The review recommends that Scottish Infected Blood Support Scheme beneficiaries should be able to self-assess regarding the effect hepatitis C has had on their life, and which level of payment they are entitled to as a result. In October 2018, the Scottish Government confirmed it would accept the recommendations of this report.
